Lassman AB - Search Results

1

Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours.

Mair MJ, Bartsch R, Le Rhun E, Berghoff AS, Brastianos PK, Cortes J, Gan HK, Lin NU, Lassman AB, Wen PY, Weller M, van den Bent M, Preusser M. Mair MJ, et al. Among authors: lassman ab. Nat Rev Clin Oncol. 2023 Jun;20(6):372-389. doi: 10.1038/s41571-023-00756-z. Epub 2023 Apr 21. Nat Rev Clin Oncol. 2023. PMID: 37085569 Review.

2

Salvage temozolomide for prior temozolomide responders.

Franceschi E, Omuro AM, Lassman AB, Demopoulos A, Nolan C, Abrey LE. Franceschi E, et al. Among authors: lassman ab. Cancer. 2005 Dec 1;104(11):2473-6. doi: 10.1002/cncr.21564. Cancer. 2005. PMID: 16270316 Free article.

3

Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma.

Khasraw M, Lassman AB. Khasraw M, et al. Among authors: lassman ab. Nat Rev Neurol. 2009 Dec;5(12):646-7. doi: 10.1038/nrneurol.2009.194. Nat Rev Neurol. 2009. PMID: 19953115 No abstract available.

4

Bevacizumab for recurrent ependymoma.

Green RM, Cloughesy TF, Stupp R, DeAngelis LM, Woyshner EA, Ney DE, Lassman AB. Green RM, et al. Among authors: lassman ab. Neurology. 2009 Nov 17;73(20):1677-80. doi: 10.1212/WNL.0b013e3181c1df34. Neurology. 2009. PMID: 19917990 Free PMC article.

5

Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.

Chow DS, Qi J, Guo X, Miloushev VZ, Iwamoto FM, Bruce JN, Lassman AB, Schwartz LH, Lignelli A, Zhao B, Filippi CG. Chow DS, et al. Among authors: lassman ab. AJNR Am J Neuroradiol. 2014 Mar;35(3):498-503. doi: 10.3174/ajnr.A3724. Epub 2013 Aug 29. AJNR Am J Neuroradiol. 2014. PMID: 23988756 Free PMC article.

6

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.

Chamberlain MC, Lassman AB, Iwamoto FM. Chamberlain MC, et al. Among authors: lassman ab. Neurology. 2010 Apr 13;74(15):1239-41. doi: 10.1212/WNL.0b013e3181d8a293. Neurology. 2010. PMID: 20385899 No abstract available.

7

Glioma oncogenesis and animal models of glioma formation.

Lyustikman Y, Lassman AB. Lyustikman Y, et al. Among authors: lassman ab. Hematol Oncol Clin North Am. 2006 Dec;20(6):1193-214. doi: 10.1016/j.hoc.2006.09.005. Hematol Oncol Clin North Am. 2006. PMID: 17113459

8

Therapeutic advances in malignant glioma: current status and future prospects.

Robins HI, Lassman AB, Khuntia D. Robins HI, et al. Among authors: lassman ab. Neuroimaging Clin N Am. 2009 Nov;19(4):647-56. doi: 10.1016/j.nic.2009.08.015. Neuroimaging Clin N Am. 2009. PMID: 19959010 Review.

9

Unraveling molecular markers of biologic therapies in glioma.

Lassman AB, Abrey LE. Lassman AB, et al. Curr Neurol Neurosci Rep. 2006 May;6(3):185-6. doi: 10.1007/s11910-006-0003-1. Curr Neurol Neurosci Rep. 2006. PMID: 16635425 No abstract available.

10

Metastases to the pineal gland.

Lassman AB, Bruce JN, Fetell MR. Lassman AB, et al. Neurology. 2006 Oct 10;67(7):1303-4. doi: 10.1212/01.wnl.0000238516.29603.33. Neurology. 2006. PMID: 17030775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page